Cargando…
Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors
Adoptive cell therapy with chimeric antigen receptors (CAR) T cells has proven effective for hematologic malignancies, but success in solid tumors has been impeded by poor intratumoral infiltration, exhaustion of effector cells from antigen burden, and an immunosuppressive tumor microenvironment. Re...
Autores principales: | Kimura, Yasushi, Ghosn, Mario, Cheema, Waseem, Adusumilli, Prasad S., Solomon, Stephen B., Srimathveeralli, Govindarajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752905/ https://www.ncbi.nlm.nih.gov/pubmed/35036524 http://dx.doi.org/10.1016/j.omto.2021.12.018 |
Ejemplares similares
-
Advancing together and moving forward: Combination gene and cellular immunotherapies
por: Priceman, Saul J., et al.
Publicado: (2022) -
Shifting, overlapping and expanding use of “precision oncology” terminology: a retrospective literature analysis
por: Tran, Audrey, et al.
Publicado: (2020) -
Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants
por: Hofmann, Marco H., et al.
Publicado: (2022) -
DNA-protein biomarkers for immunotherapy in the era of precision oncology
por: Kim, Binnari, et al.
Publicado: (2021) -
Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver
por: Deshpande, Anagha, et al.
Publicado: (2022)